“Cost-effectiveness of sacubitril/valsartan in chronic heart-failure patients with reduced ejection fraction”, Swiss Med Wkly, vol. 147, no. 4546, p. w14533, Nov. 2017, doi: 10.4414/smw.2017.14533.